Trials / Conditions / HER2-positive Solid Tumor
HER2-positive Solid Tumor
6 registered clinical trials studyying HER2-positive Solid Tumor — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | TGW211 for Click-Cleavable Imaging in HER2-Positive Cancers. NCT07009184 | Radboud University Medical Center | EARLY_Phase 1 |
| Recruiting | Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor NCT05523947 | Yuhan Corporation | Phase 1 / Phase 2 |
| Withdrawn | 89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Tr NCT04757090 | Washington University School of Medicine | Phase 2 |
| Completed | KN026 Combined With KN046 in Subjects With HER2 Positive Solid Tumor NCT04040699 | Peking University | Phase 1 |
| Completed | PRS-343 in Combination With Atezolizumab in HER2-Positive Solid Tumors NCT03650348 | Pieris Pharmaceuticals, Inc. | Phase 1 |
| Completed | PRS-343 in HER2-Positive Solid Tumors NCT03330561 | Pieris Pharmaceuticals, Inc. | Phase 1 |